Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
1987-5-20
|
| pubmed:abstractText |
A "two-site" immunoradiometric assay (IRMA) which allows the direct estimation of human CRH (hCRH) in plasma is described. Using this IRMA, basal levels of CRH in normal subjects ranged from 2-28 pg/mL [mean, 15 +/- 7 (+/- SD) pg/mL; n = 58]. Values in men and women were similar. Plasma CRH values within this range were also found in patients with Cushing's syndrome, Addison's disease, and Nelson's syndrome, with no correlation between plasma CRH and ACTH levels in these patients. Elevated plasma CRH levels were found in pregnant women near term [1462 +/- 752 (+/- SD) pg/mL; n = 55], and the dilution curve of this CRH-like immunoreactivity paralleled the IRMA standard curve. After its immunoadsorption from maternal plasma, this CRH-like material eluted on reverse phase high performance liquid chromatography with a retention time identical to that of synthetic CRH and had equipotent bioactivity with the synthetic peptide in the perfused anterior pituitary cell bioassay. Circulating CRH was not detected in Wistar rats, even after adrenalectomy and subsequent ether stress. Synthetic hCRH was degraded by fresh human plasma relatively slowly; 65% of added CRH remained after 1 h of incubation at 37 C. Degradation was inhibited by heat treatment (54 C; 1 h), cold treatment (4 C; 4 h), or freezing and thawing. Loss of synthetic rat CRH occurred more rapidly when fresh rat plasma was used; only 20% of added CRH remained under the same conditions. The inability to measure CRH in peripheral rat plasma may be due to the presence of active CRH-degrading enzymes which fragment the CRH molecule into forms not recognized by the CRH IRMA.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
May
|
| pubmed:issn |
0021-972X
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
64
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1047-53
|
| pubmed:dateRevised |
2008-11-21
|
| pubmed:meshHeading |
pubmed-meshheading:3494035-Addison Disease,
pubmed-meshheading:3494035-Adrenalectomy,
pubmed-meshheading:3494035-Animals,
pubmed-meshheading:3494035-Biological Assay,
pubmed-meshheading:3494035-Chromatography, High Pressure Liquid,
pubmed-meshheading:3494035-Corticotropin-Releasing Hormone,
pubmed-meshheading:3494035-Cushing Syndrome,
pubmed-meshheading:3494035-Female,
pubmed-meshheading:3494035-Humans,
pubmed-meshheading:3494035-Immunoassay,
pubmed-meshheading:3494035-Iodine Radioisotopes,
pubmed-meshheading:3494035-Male,
pubmed-meshheading:3494035-Nelson Syndrome,
pubmed-meshheading:3494035-Pituitary Gland, Anterior,
pubmed-meshheading:3494035-Pregnancy,
pubmed-meshheading:3494035-Rats,
pubmed-meshheading:3494035-Reference Values,
pubmed-meshheading:3494035-Stress, Physiological
|
| pubmed:year |
1987
|
| pubmed:articleTitle |
Direct measurement of human plasma corticotropin-releasing hormone by "two-site" immunoradiometric assay.
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|